Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Crissy T. Kawamoto is active.

Publication


Featured researches published by Crissy T. Kawamoto.


BMC Oral Health | 2014

The reasons for betel-quid chewing scale: assessment of factor structure, reliability, and validity

Melissa A. Little; Pallav Pokhrel; Kelle L. Murphy; Crissy T. Kawamoto; Gil S. Suguitan; Thaddeus A. Herzog

BackgroundDespite the fact that betel-quid is one of the most commonly used psychoactive substances worldwide and a major risk-factor for head-and-neck cancer incidence and mortality globally, currently no standardized instrument is available to assess the reasons why individuals chew betel-quid. A measure to assess reasons for chewing betel-quid could help researchers and clinicians develop prevention and treatment strategies. In the current study, we sought to develop and evaluate a self-report instrument for assessing the reasons for chewing betel quid which contributes toward the goal of developing effective interventions to reduce betel quid chewing in vulnerable populations.MethodsThe current study assessed the factor structure, reliability and convergent validity of the Reasons for Betel-quid Chewing Scale (RBCS), a newly developed 10 item measure adapted from several existing “reasons for smoking” scales. The measure was administered to 351 adult betel-quid chewers in Guam.ResultsConfirmatory factor analysis of this measure revealed a three factor structure: reinforcement, social/cultural, and stimulation. Further tests revealed strong support for the internal consistency and convergent validity of this three factor measure.ConclusionThe goal of designing an intervention to reduce betel-quid chewing necessitates an understanding of why chewers chew; the current study makes considerable contributions towards that objective.


Addictive Behaviors | 2014

Correlates of use of electronic cigarettes versus nicotine replacement therapy for help with smoking cessation.

Pallav Pokhrel; Melissa A. Little; Pebbles Fagan; Crissy T. Kawamoto; Thaddeus A. Herzog

INTRODUCTION Electronic- or e-cigarettes are nicotine-delivery devices commonly used by smokers to quit or reduce smoking. At present, not much is known about the characteristics of smokers who specifically try e-cigarettes to quit smoking compared to the nicotine replacement therapy (NRT) products approved by the U.S. Food and Drug Administration (FDA). Determining the characteristics of smokers who are likely to choose e-cigarettes as cessation aids would help develop strategies to impart valid information about e-cigarettes to such smokers as facts regarding the safety and utility of e-cigarettes emerge. METHODS This study is based on 834 daily smokers [mean age=45.8 (standard deviation=13)] from Hawaii. Demographic, smoking- and cessation-related variables were examined as correlates of ever use of e-cigarette only or any FDA-approved NRT product only or both as cessation aids. RESULTS Results indicated that younger smokers, non-White smokers, and smokers reporting higher income, lower nicotine dependence, shorter smoking history, and higher lifetime quit attempts were more likely to have tried e-cigarettes but not NRT products for help with smoking cessation. CONCLUSION Smokers who are attracted to use e-cigarettes but not FDA-approved NRT products may differ from smokers who are likely to have used NRT products but not e-cigarettes in terms of demographic (e.g., age, ethnicity) and smoking- or cessation-related characteristics (e.g., nicotine dependence, quit attempts). Given the lack of knowledge regarding the health effects of e-cigarettes and their efficacy as cessation aids, future research needs to continue characterizing smokers who are likely to use e-cigarettes for smoking cessation.


Substance Use & Misuse | 2015

Short-term fluctuations in motivation to quit smoking in a sample of smokers in Hawaii.

Thaddeus A. Herzog; Pallav Pokhrel; Crissy T. Kawamoto

Background: Despite its potential for usefulness in informing the development of smoking cessation interventions, short-term fluctuations in motivation to quit is a relatively understudied topic. Objectives: To assess the prevalence of smokers’ day-to-day fluctuations in motivation to quit, and to assess associations of day-to-day fluctuations in motivation to quit with several established cessation-related variables. Methods: A cross-sectional survey was administered to smokers in Hawaii (N = 1,567). To assess short-term fluctuations in motivation to quit smoking, participants were asked to respond “True” or “False” to the statement: “My motivation to quit smoking changes from one day to the next.” Other items measured desire to quit smoking, intention to quit, confidence in quitting, cigarette dependence, and other cessation-related variables. Results: “My motivation to quit smoking changes from one day to the next” was endorsed as true by 64.7% of smokers, and false by 35.3%. Analyses revealed that smokers who indicated fluctuating motivation were significantly more interested in quitting as compared to smokers without fluctuations. Fluctuations in motivation to quit also were associated with greater confidence in quitting, lesser cigarette dependence, and more recent quitting activity (all p < .01). Conclusions: Day-to-day fluctuations in motivation to quit are common. Day-to-day fluctuations in motivation to quit are strongly associated with higher motivation to quit, greater confidence in future quitting, and other positive cessation-relevant trends.


Nicotine & Tobacco Research | 2018

Sugar and Aldehyde Content in Flavored Electronic Cigarette Liquids

Pebbles Fagan; Pallav Pokhrel; Thaddeus A. Herzog; Eric T. Moolchan; Kevin Cassel; Adrian A. Franke; Xingnan Li; Ian Pagano; Dennis R. Trinidad; Kari-Lyn Sakuma; Kymberle L. Sterling; Dorothy Jorgensen; Tania Lynch; Crissy T. Kawamoto; Mignonne C. Guy; Ian Lagua; Sarah Hanes; Linda A. Alexander; Mark S. Clanton; Camonia Graham-Tutt; Thomas Eissenberg; Addictive Carcinogens Workgroup

Introduction Sugars are major constituents and additives in traditional tobacco products, but little is known about their content or related toxins (formaldehyde, acetaldehyde, and acrolein) in electronic cigarette (e-cigarette) liquids. This study quantified levels of sugars and aldehydes in e-cigarette liquids across brands, flavors, and nicotine concentrations (n = 66). Methods Unheated e-cigarette liquids were analyzed using liquid chromatography mass spectrometry and enzymatic test kits. Generalized linear models, Fishers exact test, and Pearsons correlation coefficient assessed sugar, aldehyde, and nicotine concentration associations. Results Glucose, fructose and sucrose levels exceeded the limits of quantification in 22%, 53% and 53% of the samples. Sucrose levels were significantly higher than glucose [χ2(1) = 85.9, p < .0001] and fructose [χ2(1) = 10.6, p = .001] levels. Formaldehyde, acetaldehyde, and acrolein levels exceeded the limits of quantification in 72%, 84%, and 75% of the samples. Acetaldehyde levels were significantly higher than formaldehyde [χ2(1) = 11.7, p = .0006] and acrolein [χ2(1) = 119.5, p < .0001] levels. Differences between nicotine-based and zero-nicotine labeled e-cigarette liquids were not statistically significant for sugars or aldehydes. We found significant correlations between formaldehyde and fructose (-0.22, p = .004) and sucrose (-0.25, p = .002) and acrolein and fructose (-0.26, p = .0006) and sucrose (-0.21, p = .0006). There were no significant correlations between acetaldehyde and any of the sugars or any of the aldehydes and glucose. Conclusions Sugars and related aldehydes were identified in unheated e-cigarette liquids and their composition may influence experimentation in naïve users and their potential toxicity. Implications The data can inform the regulation of specific flavor constituents in tobacco products as a strategy to protect young people from using e-cigarettes, while balancing FDAs interest in how these emerging products could potentially benefit adult smokers who are seeking to safely quit cigarette smoking. The data can also be used to educate consumers about ingredients in products that may contain nicotine and inform future FDA regulatory policies related to product standards and accurate and comprehensible labeling of e-cigarette liquids.


Tobacco regulatory science | 2017

Comparison of Measures of E-cigarette Advertising Exposure and Receptivity

Pallav Pokhrel; Pebbles Fagan; Thaddeus A. Herzog; Simone Schmid; Crissy T. Kawamoto; Jennifer B. Unger

Objectives We tested how various measures of e-cigarette advertising exposure and receptivity are related to each other and compare to each other in their associations with e-cigarette use susceptibility and behavior. Methods Cross-sectional data were collected from young adult college students (N = 470; Mage = 20.9, SD = 2.1; 65% women). Measures of e-cigarette advertising exposure/receptivity compared included a cued recall measure, measures of marketing receptivity, perceived ad exposure, liking of e-cigarette ads, and frequency of convenience store visit, which is considered a measure of point-of-sale ad exposure. Results The cued-recall measure was associated with e-cigarette use experimentation but not current e-cigarette use. Marketing receptivity was associated with current e-cigarette use but not e-cigarette use experimentation. Liking of e-cigarette ads was the only measure associated with e-cigarette use susceptibility. Frequency of convenience store visit was associated with current e-cigarette use but not e-cigarette use experimentation or susceptibility. Conclusion Inclusion of multiple measures of marketing exposure and receptivity is recommended for regulatory research concerning e-cigarette marketing. Marketing receptivity and cued recall measures are strong correlates of current and ever e-cigarette use, respectively.


Preventive medicine reports | 2015

Menthol cigarette smoking and obesity in young adult daily smokers in Hawaii

Alyssa Antonio; Pebbles Fagan; Faith D. Hamamura; Ian Lagua; Jenny Liu; Devin J. Park; Pallav Pokhrel; Thaddeus A. Herzog; Ian Pagano; Kevin Cassel; Angela Sy; Dorothy Jorgensen; Tania Lynch; Crissy T. Kawamoto; Carol J. Boushey; Adrian A. Franke; Mark S. Clanton; Eric T. Moolchan; Linda A. Alexander

This study investigates 1) the relationship between menthol cigarette smoking and obesity and 2) the association of body mass index with the nicotine metabolite ratio among menthol and non-menthol daily smokers aged 18–35 (n = 175). A brief survey on smoking and measures of height and weight, carbon monoxide, and saliva samples were collected from participants from May to December 2013 in Honolulu, Hawaii. Multiple regression was used to estimate differences in body mass index among menthol and non-menthol smokers and the association of menthol smoking with obesity. We calculated the log of the nicotine metabolite ratio to examine differences in the nicotine metabolite ratio among normal, overweight, and obese smokers. Sixty-eight percent of smokers used menthol cigarettes. Results showed that 62% of normal, 54% of overweight, and 91% of obese smokers used menthol cigarettes (p = .000). The mean body mass index was significantly higher among menthol compared with non-menthol smokers (29.4 versus 24.5, p = .000). After controlling for gender, marital status, educational attainment, employment status, and race/ethnicity, menthol smokers were more than 3 times as likely as non-menthol smokers to be obese (p = .04). The nicotine metabolite ratio was significantly lower for overweight menthol smokers compared with non-menthol smokers (.16 versus .26, p = .02) in the unadjusted model, but was not significant after adjusting for the covariates. Consistent with prior studies, our data show that menthol smokers are more likely to be obese compared with non-menthol smokers. Future studies are needed to determine how flavored tobacco products influence obesity among smokers.


Cancer Epidemiology, Biomarkers & Prevention | 2015

Abstract IA47: Resolving the complex problem of tobacco-caused lung cancer disparities in the U.S

Pebbles Fagan; Eric T. Moolchan; Pallav Pokhrel; Thaddeus A. Herzog; Kevin Cassel; Ian Pagano; Adrian A. Franke; Joseph Keawe‘aimoku Kaholokula; Angela Sy; Linda A. Alexander; Dennis R. Trinidad; Kari-Lyn Sakuma; Carl Anderson Johnson; Alyssa Antonio; Dorothy Jorgensen; Tania Lynch; Crissy T. Kawamoto; Mark S. Clanton

Existing data show that lung cancer disparities are not explained by cigarette smoking dose and duration alone. Data from the Multiethnic Cohort Study show that Native Hawaiians and African Americans who smoked 10 cigarettes per day have an elevated risk of lung cancer compared to Japanese American, White, and Latino smokers. Prior studies also suggest that African Americans have slower nicotine metabolism compared to Whites. It remains unclear why we consistently observe slower rates of nicotine metabolism among African Americans, but higher rates of lung cancer since studies suggest that smokers with low levels of CPY2A6 activity may be less efficient in bioactivating tobacco smoke pre-carcinogens to carcinogens. Little is known about nicotine metabolism among Native Hawaiians and Filipinos who have disproportionate and unexplained lung cancer rates like African Americans. This study compares biomarkers of tobacco smoke exposure in Native Hawaiian, Filipino, and White young adult daily smokers. We hypothesized that Native Hawaiians and Filipinos, like African Americans, would have slower nicotine metabolism compared to Whites. We collected data on sociodemographics, smoking history, and psychosocial risk factors among young adult daily smokers aged 18-35. We measured height, weight, and carbon monoxide levels among all smokers. A saliva sample was collected from each smoker using standard passive drool procedures. The geometric means were calculated for nicotine, cotinine, trans 39 hydroxycotinine, the nicotine metabolite ratio, and expired carbon monoxide and the data were compared among racial/ethnic groups. Two analysis of covariance models tested biomarker differences among racial/ethnic groups. Model 1, the unadjusted model, contained no covariates. Model 2 included gender, body mass index (BMI), menthol smoking status, Hispanic ethnicity, and the number of cigarettes smoked per day as covariates. The sample included 44% Native Hawaiians, 16% Filipinos, and 40% Whites (n=186). Twenty-four percent of young adults were of Hispanic origin, 48% were females, and smokers had a mean BMI of 28. Forty-one percent of Filipino smokers reported Hispanic ethnicity compared to 27% of Native Hawaiian and 15% of White smokers (p In the unadjusted and adjusted models, cotinine levels were higher among Native Hawaiians compared to Whites, but these differences were not significant among racial/ethnic groups. In the unadjusted model, the nicotine metabolic ratio was significantly lower in Native Hawaiian and Filipino smokers compared to White smokers (NMR: 0.17, 0.15, 0.27, p In summary, our data show that Native Hawaiian and Filipino daily smokers have slower nicotine metabolism than White daily smokers as indicated by the nicotine metabolite ratio. Studies show that the nicotine metabolite ratio is a reliable phenotypic marker for CYP2A6 activity. However, is it not clear whether the algorithm suggesting that slow nicotine metabolizers have reduced lung cancer risk applies to all racial/ethnic groups. Resolving the complex problem of lung cancer disparities requires further investigation of multiple biological pathways to determine which lung cancer risk algorithms apply to specific racial/ethnic groups. Such investigations will allow to us to improve community, clinical, and policy-based interventions to reduce disparities. Citation Format: Pebbles Fagan, Eric T. Moolchan, Pallav Pokhrel, Thaddeus Herzog, Kevin Cassel, Ian Pagano, Adrian Franke, Joseph Keawe9aimoku Kaholokula, Angela Sy, Linda A. Alexander, Dennis R. Trinidad, Kari-Lyn Sakuma, Carl Anderson Johnson, Alyssa M. Antonio, Dorothy Jorgensen, Tania Lynch, Crissy Kawamoto, Mark S. Clanton. Resolving the complex problem of tobacco-caused lung cancer disparities in the U.S. [abstract]. In: Proceedings of the Seventh AACR Conference on The Science of Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; Nov 9-12, 2014; San Antonio, TX. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2015;24(10 Suppl):Abstract nr IA47.


Cancer Prevention Research | 2011

Abstract B37: Ethnic differences in smoking rate, nicotine dependence, and cessation-related variables among adult smokers in Hawaii

Thaddeus A. Herzog; Pallav Pokhrel; Crissy T. Kawamoto

Introduction : This study tests hypotheses concerning ethnic disparities in daily cigarette smoking rate, nicotine dependence, cessation motivation, and knowledge and past use of cessation methods (e.g., counseling) and products (e.g., nicotine patch) in a multi-ethnic sample of smokers in Hawaii. Previous research has revealed significant differences in smoking prevalence among Native Hawaiians, Filipinos, Japanese, and Caucasians in Hawaii. However, no study has examined differences in dependence and cessation-related knowledge and practices among smokers representing these ethnic groups. Methods : Participants were recruited through newspaper advertisement as part of a larger smoking cessation intervention study. Participants (N=919; M age=45.6, SD=12.7; 48% female) eligible to participate provided self-report data through mail and telephone. Subjects included 271 self-identified Native Hawaiians, 63 Filipinos, 316 Caucasians, 145 “Asians” (e.g., Japanese, Chinese), and 124 “Other” (e.g., Hispanic, African-American). Results : Pair-wise comparisons of means, controlling for age, gender, income, education, and marital status, indicated that Native Hawaiian smokers reported statistically significantly higher daily smoking rates and higher levels of nicotine dependence compared to Asians. Native Hawaiian smokers reported significantly lower motivation to quit smoking as compared to Caucasians. Further, Filipino, and Native Hawaiian smokers reported lesser knowledge of cessation methods and products, and less frequent use of these methods and products compared to Caucasians. Conclusions : The results suggest that Native Hawaiian and Filipino smokers could be under-served with regard to receiving cessation-related advice, and may lack adequate access to smoking cessation products and services. In addition, cessation interventions tailored for Native Hawaiian smokers could benefit from a motivational enhancement component. Citation Information: Cancer Prev Res 2011;4(10 Suppl):B37.


American Journal of Public Health | 2013

Smokers Who Try E-Cigarettes to Quit Smoking: Findings From a Multiethnic Study in Hawaii

Pallav Pokhrel; Pebbles Fagan; Melissa A. Little; Crissy T. Kawamoto; Thaddeus A. Herzog


Drug and Alcohol Dependence | 2014

The Betel Quid Dependence Scale: Replication and extension in a Guamanian sample

Thaddeus A. Herzog; Kelle L. Murphy; Melissa A. Little; Gil S. Suguitan; Pallav Pokhrel; Crissy T. Kawamoto

Collaboration


Dive into the Crissy T. Kawamoto's collaboration.

Top Co-Authors

Avatar

Pallav Pokhrel

University of Hawaii at Manoa

View shared research outputs
Top Co-Authors

Avatar

Thaddeus A. Herzog

University of Hawaii at Manoa

View shared research outputs
Top Co-Authors

Avatar

Pebbles Fagan

University of Arkansas for Medical Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Melissa A. Little

University of Tennessee Health Science Center

View shared research outputs
Top Co-Authors

Avatar

Dorothy Jorgensen

University of Hawaii at Manoa

View shared research outputs
Top Co-Authors

Avatar

Eric T. Moolchan

National Institute on Drug Abuse

View shared research outputs
Top Co-Authors

Avatar

Kevin Cassel

University of Hawaii at Manoa

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge